Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 09, 2020

SELL
$1.62 - $4.24 $36,142 - $94,594
-22,310 Closed
0 $0
Q2 2020

Jul 20, 2020

BUY
$1.19 - $2.27 $12,129 - $23,138
10,193 Added 84.12%
22,310 $44,000
Q1 2020

Apr 30, 2020

BUY
$1.11 - $2.43 $13,449 - $29,444
12,117 New
12,117 $18,000

Others Institutions Holding CKPT

About Checkpoint Therapeutics, Inc.


  • Ticker CKPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,497,000
  • Market Cap $245M
  • Description
  • Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...
More about CKPT
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.